Lemborexant Respiratory Safety Data Presented at SLEEP 2019

WOODCLIFF LAKE, N.J., June 11, 2019 /PRNewswire/ --Eisai Inc. today announced data on the respiratory safety of investigational lemborexant with multiple and single dosing in healthy adult and elderly individuals, as well as in those with mild obstructive sleep apnea (OSA).